CARLSBAD, Calif.– Translational researchers who previously could not obtain global gene expression profiles from biobank samples due to limited amounts of tissue now have access to a wealth of valuable RNA data with the launch of theIon AmpliSeq Transcriptome Solution for the Ion Proton System. The ability to mine many years worth of samples for […]
SANTA CLARA, Calif. -– Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia. Designed in collaboration with Dr. Robert Ohgami and Dr. Daniel Arber at […]
SAN CARLOS, Calif.– NuGEN Technologies, Inc., a market leader in the development of solutions for Next Generation Sequencing (NGS) applications, has announced the release of a novel targeted enrichment method that, in a single assay, will detect all possible fusion events involving 446 cancer fusion genes as curated by the Wellcome Trust Sanger Institute’s Catalog […]
Provo, Utah — Tute Genomics is today teaming up with UK-based Patients Know Best – the world’s first fully patient controlled medical records system – to make ‘precision medicine’ a reality to patients across the globe. Operating a cloud-based software platform, Tute Genomics specializes in genome analysis, creating meaningful reports of an individual’s full genomic […]
ST LOUIS, MO -– Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today announced the release of Variant Annotation and Analysis (VAA) Suite for identifying causal variants in next-generation sequencing (NGS) data. Building on and extending leading tools for annotating, filtering, and visualizing mutations […]
RARITAN, N.J.– Janssen Diagnostics, LLC today announced the addition of next-generation sequencing (NGS) to the portfolio of services it provides pharmaceutical and academic researchers. With this announcement, Janssen Diagnostics continues to drive innovative solutions for its lab services customers by expanding its lab services offering in rare cell detection beyond its core competencies: the gold-standard […]
AstraZeneca today announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio. In the first instance, AstraZeneca intends to apply Illumina’s cutting-edge technology to a novel companion diagnostic test in pivotal studies for one […]
The Ion PGM is a fast and cost-effective platform for next generation sequencing applications. The release of the Ion TrueMate™ Library Kit will expand the platform’s capabilities by allowing long mate pair libraries up to 8 kb to be run on the PGM. Mate pair libraries are critical for de novo genome assembly, chromosomal rearrangement […]
Thermo Fisher Scientific Launches First Clinical Next-Generation Sequencing Oncology Quality Control
CARLSBAD, Calif.– Clinical laboratories running next-generation sequencing (NGS) oncology tests now have access to a universal quality control material compatible with multiple sequencing platforms. The AcroMetrix Oncology Hotspot Control provides a common quality control material that can be used across laboratories with different NGS instrument platforms, assays and bioinformatics pipelines to test precision and detect […]
PALO ALTO, Calif. — Cellular Research announced today the start of an early access program for its Precise™ assays and is currently making the product available to 10 sites. The Precise assays provide ultra-sensitive RNASeq assay technology designed to examine large numbers of standard or low input mRNA samples in high throughput. Based on Cellular […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
